When doctors talk about disease progression, they usually break it down into stages. MS can also be divided into stages. But they aren’t quite like cancer stages that have a clear progression.
Instead, your disease progression and stage depend on the type of MS you have, your symptoms, and how much they affect your daily life — for instance, whether or not they cause disability.
This article will cover how MS progresses, the stages of disability, and life expectancy. We’ll also look at whether highly effective disease-modifying therapies (HE-DMTs) can help slow disease worsening and improve the prognosis (outlook).
MS generally progresses in two different ways. The form of MS you have usually affects how your disease worsens.
Relapse-associated worsening (RAW) occurs when you can’t completely recover from a relapse. A relapse refers to a time when your MS symptoms “flare” or get worse. A relapse is also known as an exacerbation.

At first, your body is able to recover from the inflammation and attacks on your central nervous system (CNS). As damage builds up over time, it becomes harder to recover and reach remission. People with relapsing-remitting MS (RRMS) usually progress because of RAW.
The second way MS progresses is by progression independent of relapse activity (PIRA). This means your MS symptoms keep getting worse — even without relapses or flare-ups.
PIRA is usually responsible for progression in people with nonrelapsing MS. This includes:
However, one large study of people with MS found that those with RRMS also experience PIRA. It’s just less common than in PPMS and SPMS.
Up to half of all worsening disability wasn’t directly caused by relapses. This means that progression happens even without MS flare-ups for many people.
MS is a neurological condition that develops when your immune system attacks your body. Specifically, MS is an autoimmune disease that attacks your CNS — which includes your brain, optic nerve, and spinal cord.
Immune cells damage the fatty coating on your nerve cells called the myelin sheath. Myelin protects your nerve cells and helps them send signals to each other.
Lesions form in areas along the nerve with demyelination. Lesions are scars from CNS damage, meaning the myelin sheath is missing.
Over time, damage to the CNS affects how well your nerves communicate with the rest of your body. The location and severity of the damage affects your symptoms and disease progression.

Doctors can see lesions on the brain and spinal cord with MRI scans. Your lesions can look different depending on the type of MS and inflammation you have.
For example, lesions from PIRA look different than those caused by relapses. Researchers are still looking into why these lesions are different and what it means for MS progression.
Most studies looking at MS progression use the Expanded Disability Status Scale (EDSS) to measure disability. The EDSS looks at how much MS affects your daily life and causes disability.
To get your EDSS score, your doctor will ask questions about your symptoms. They’ll try to find out about changes in:
The EDSS is measured on a scale of 0 through 10. The higher your score, the more MS affects you and the more disability you have.
As MS progresses, your EDSS score will increase. Generally speaking, your MS is progressing if, over the course of six months:
For example, you may have an EDSS score of 5.0. This means you have significant disability that affects your daily activities. However, you can walk shorter distances without a cane or walker to help.
After six months, you need a mobility aid to help you walk. You also can only walk around 300 feet at a time, and you may need to stop for rest. Your new EDSS score is now a 6.0.
In this example, your doctor would consider your MS as progressing. Your symptoms got worse over a period of six months by at least one point in your EDSS score.
MS is a progressive disease that continues worsening over time. Doctors can divide the stages of MS progression by your symptoms and disability with your EDSS score.
The subclinical phase is the first stage of MS. You may have some inflammation and CNS damage before showing any symptoms of MS. However, it’s too early to diagnose MS at this point.
The high-risk phase is the second stage of early MS. You’ll start having MS symptoms at this point.
The relapsing-remitting phase involves periods of relapse and periods of remission. You’ll go through cycles of MS flare-ups with symptoms. Once those symptoms go away, you’re in remission.
The final stage of MS is known as the progressive phase. At this point, your flare-ups last longer than your periods of remission.
Some people lose their remissions entirely. It’s important to note that not everyone with RRMS will enter the progressive phase.
MS life expectancy is often close to typical life expectancy, though studies suggest MS may shorten lifespan by about two to seven years. New treatments have helped improve life expectancy in recent years.

When MS enters its progressive phase, your symptoms may continue worsening over time. MS itself isn’t usually the cause of death in people with the condition. Instead, people tend to have other health problems, like:
The mainstay treatment for relapsing MS is DMTs. These medications don’t just treat MS symptoms — they may also help slow disease progression.
A large study of people with MS compared people who used DMTs to those who took a placebo (inactive substance).
People treated with DMTs took 12.5 years to reach an EDSS score of 4. The people who took the placebo reached the same score in 9 years. This means that DMTs delayed disease progression by 3.5 years.
People with RRMS who take HE-DMTs have fewer relapses and less CNS damage. Some can even improve their EDSS scores with the right treatment. Other people see their EDSS scores stay stable without symptom worsening.
Since HE-DMTs are relatively new, we don’t know exactly how they affect disease course and life expectancy yet. Some reports suggest that DMTs can help people with MS live longer.
However, researchers aren’t sure if this is because of DMT treatment or other lifestyle choices. More studies are looking into how these medications help slow progression and improve life expectancy.
Each person’s multiple sclerosis progression timeline is different. Talk with your neurologist about how well your MS treatment plan is working for you to slow disease progression. They can also discuss your individual risks for progression and what else you can do to improve your prognosis.
On MyMSTeam, people share their experiences with multiple sclerosis, get advice, and find support from others who understand.
How has your multiple sclerosis progressed over time? Let others know in the comments below.
Get updates directly to your inbox.
Become a member to get even more
This is a member-feature!
Sign up for free to view article comments.
We'd love to hear from you! Please share your name and email to post and read comments.
You'll also get the latest articles directly to your inbox.